Diabetes MNT
BehavioralGroup-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake
NCT Number: NCT04971889
A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.
This study is active but is not currently recruiting participants.
Notify Me21 year and older
Female
Interventional
Not applicable
Matthew Walker Comprehensive Health Center, Nashville, Tennessee, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
--Observed or diagnosed psychotic disorders
Group-based MNT sessions that provide evidence-based dietary self-care information, behavioral skills, and goal setting related to managing carbohydrate and fat intake
Group-based support for dietary self-care motivation using culturally-adapted motivational interviewing exercise
Time frame: Baseline
Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Time frame: 3 months
Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Time frame: 6 months
Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Time frame: 12 months
Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.
Time frame: Baseline
Calculated measure of body max index from height/weight measures
Time frame: 3 months
Calculated measure of body max index from height/weight measures
Time frame: 6 months
Calculated measure of body max index from height/weight measures
Time frame: 12 months
Calculated measure of body max index from height/weight measures
Time frame: Baseline
Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Time frame: 3 months
Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Time frame: 6 months
Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Time frame: 12 months
Standard enzymatic laboratory procedures will be used to assess total cholesterol, HDL cholesterol, and triglycerides from whole blood. LDL will be calculated based on total cholesterol and HDL values.
Time frame: Baseline
A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Time frame: 3 months
A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Time frame: 6 months
A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Time frame: 12 months
A sphygmometer will be assessed to assess systolic blood pressure fifteen minutes after participant is in a seated position with their arm elevated.
Time frame: Baseline
Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Time frame: 3 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Time frame: 6 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Time frame: 12 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for carbohydrate management.
Time frame: Baseline
Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Time frame: 3 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Time frame: 6 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Time frame: 12 months
Uses a Likert question format (n=12) and assesses attitudes and motivation for dietary fat management.
Time frame: Baseline
Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Time frame: 3 months
Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Time frame: 6 months
Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Time frame: 12 months
Uses a Likert question format (n=8) and assesses motivation for overall diabetes self-care.
Time frame: Baseline
Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.
Time frame: 3 months
Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.
Time frame: 6 months
Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.
Time frame: 12 months
Uses a Likert question (n=20) format and assesses patients' problems in applying various self-care areas, including dietary self-care skills.
Time frame: Baseline
Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Time frame: 3 months
Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Time frame: 6 months
Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Time frame: 12 months
Uses a Likert question (n=6) format and assesses self-efficacy in adhering to dietary recommendations and managing situations that make adherence challenging (e.g., social activities including few healthy food options.
Meharry Medical College
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05710900
Diabetes Mellitus, Diabetes Mellitus, Type 2
Kelowna, British Columbia, Canada
View Trial DetailsNCT07400653
Body Weight, Diabetes Mellitus
Anaheim, California, United States
View Trial DetailsNCT05040087
Diabetes Mellitus, Diabetes Mellitus, Type 2
Decatur, Georgia, United States
View Trial DetailsNCT05360056
Diabetes Mellitus, Diabetes Mellitus, Type 2
Columbus, Ohio, United States
View Trial Details